Linear growth in homozygous β-thalassemia and β-thalassemia/hemoglobin E patients under different treatment regimens

Journal of the Medical Association of Thailand

Volumn 84, Issue 7, 2001, Pages 929-941

  Viprakasit, Vip ^a   Mahasandana, Chularatana ^a   Suwantol, Lerlugsn ^a   Kankirawatana, Suthida ^a   Suvatte, Vinai ^a   Tanphaichitr, Voravarn S ^a   Assteerawatt, Amara ^a   Veerakul, Gavivann ^a   Pung Amritt, Parichat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

thalassemia Hb E; Blood Transfusion; Homozygous thalassemia; Iron Chelation; Linear Growth

Indexed keywords

DEFEROXAMINE; IRON CHELATING AGENT;

ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; BODY WEIGHT; CHI SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; FEMALE; GROWTH DISORDER; HUMAN; LONGITUDINAL STUDY; MALE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PUBERTY; STATISTICAL MODEL;

BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; BODY WEIGHT; CHI-SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; DEFEROXAMINE; FEMALE; GROWTH DISORDERS; HUMAN; IRON CHELATING AGENTS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PUBERTY; STATISTICS, NONPARAMETRIC;

EID: 0035409398     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Wolman IJ. Transfusion therapy in Cooley's anemia : growth and health as related to longrange hemoglobin levels. Ann NY Acad Sci 1964; 119: 736.
2. Kattamis C, Touliatos N, Haidas S, Matsaniotis N. Growth of children with thalassemia : Effect of different transfusion regimens. Arch Dis Child 1970; 45: 502-5.
3. Italian Working Group on endocrine complications in non endocrine disease multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995; 42: 581-6.
4. Kattamis C, Lukopoulos T, Kattamis A. Growth and development in children with thalassemia major. Acta Paediatrica Scandinavica 1990; 366 (Suppl): 11-7.
5. Pignatti CB, De Stefano P, Zonta L, et al. Growth and sexual maturation in thalassemia major. J Pediatrics 1985; 106: 150-5.
6. Coa A, Gabutti V, Galanello R, et al. Management protocol for the treatment of thalassemia patients 1997 edition. Thalassemia Intemation Federation, Cyprus: 1997: 4-6.
7. De Sanctis V, Katz M, Vullo C, et al. Effect of different treatment regimes on linear growth and final height in β-thalassemia major. Clin Endocrinol 1994; 40: 791-8
8. Rebulia P, Modell B. Transfusion requirements and effects in patients with thalassaemia major. Lancet 1991; 337: 277-80.
9. Cavallo L, Gurrado R, Gallo F, et al. Growth deficiency in polytransfused β-thalassaemia patients is not growth hormone dependent. Clin Endocrinol 1997; 46: 701-6.
10. Olivieri N, Brittenham G. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-61.
11. th Congress of the International Society of hematology Singapore: Panache Design 1996: 226-33.
12. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia : Molecular biology and clinical medicine. Hemoglobin 1997; 21: 299-319.
13. Laosombat V. Thalassemia in children in southern Thailand. J Med Assoc Thai 1986; 69: 393-9.
14. Weatherall DJ, Clegg JB. The thalassemia syndromes, third edition. Oxford: Blackwell Scientific Publications 1981: 148-319.
15. Tuchinda C, Punnakanta L, Angusingha K, Tuchinda S. Growth failure and growth hormone response in β-thalassaemia. Siriraj Hosp Gaz 1983; 35: 983-8.
16. De Sanctis V, Tangerini A, Testa MR, et al. Final height and endocrine function in thalassaemia intermedia. J Pediatr Endocrinol Metab 1998; 11: 965-71.
17. Tienboon P, Boonma M, Sanguansermsri T. Growth retardation of the thalassemic diseases. Chiang Mai Med Bul 1984; 23: 189-96.
18. Vannasaeng S, Ploybutr S, Visutkul P, et al. Endocrine function in thalassaemia. Clin Endocrinol 1981; 14: 165-73.
19. Vannasaeng S, Fucharoen S, Pootrakul P, et al. Pituitary function in thalassemic patients and the effect of chelation therapy. Acta Endocrinol 1991; 124: 23-30.
20. Tuchinda C, Angsusingha K, Punnakanta L, Tanphaichitr VS. Adrenal function test in β-thalassemic children. J Med Assoc Thai 1984; 67: 272-6.
21. Tanphaichitr VS, Tuchinda C, Suvatte V, Tuchinda S. Bodily growth in thalassemia. Child Health in the Tropics. Sixth Nutricia-Cow and Gate symposium. Dordrecht, Netherlands: Martinus Nijhoff Publisher, 1983: 43-9.
22. Piomelli S, Loew T. Management of thalassemia major (Cooley's Anemia). Hem Oncol Clin North Am 1991; 5: 557-69.
23. Tanphaichitr VS, Suvatte V, Mahasandana C, Tuchinda S. Hypertension posttransfusion in Thai thalassemic children : Early detection and management. Birth Defects 1988; 23: 251-5.
24. van Suijlen JD, van Noord PC, Leijnse B. Accuracy of serum ferritin determination in tissue preparations and human serum. J Clin Chem & J Biochem 1990; 28: 43-8.
25. Gibson RS. Anthropometric assessment of growth. In : Principles of Nutritional Assessment. Oxford: Oxford University Press, 1990: 163-86.
26. Measuring change in nutritional status: guidelines for assessing the impact of supplementary feeding programmes for vulnerable groups. Geneva: World Health Organization, 1983.
27. Kariberg J. A new model for studying growth in children. J Pediatr Obstetr and Gynaecol 1996; 22: 5-10.
28. Zadik Z, Landau H, Limoni Y, Lieberman E. Predictors of growth response to growth hormone in otherwise normal short children. Pediatrics 1992; 121: 44-8.
29. Tanner JM, Whitehouse RH. Clinical longitudinal standard for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 107-9.
30. Modell B, Berdoukas V. Growth puberty and endocrinopathy. The Clinical Approach to Thalassemia. London: Grune & Stratton, 1981: 175-97.
31. Arcasoy A, Cavdar A, Cin S, et al. Effects of zinc supplementation on linear growth in beta-thalas-semia (a new approach). Am J Hematol 1987; 24: 127-36.
32. Prasad AS, Diwany M, Gabor M, et al. Biomedical studies in thalassemia. Ann Intern Med 1965; 47: 495-505.
33. Giardini O, Cantani A, Donfraneesco A. Vitamin E therapy in homozygous beta thalassemia. N Engl J Med 1981; 305: 644.
34. 12 and Folic acid deficiency in β-heterozygous thalassemia. Ind J Med Res 1984; 79: 783-8.
35. Maurer HS, Lloyd-Still JD, Ingrisano C, et al. A prospective evaluation of iron chelation therapy in children with severe β-thalassemia : a six year study. Am J Dis Childhood 1988; 142: 287-92.
36. De Sanctis V, Vullo C, Katz M, et al. Gonadal function in patients with β-thalassemia major. J Clin Pathol 1988; 41: 133-7.
37. Deluca G, Maggiolini M, Bria M, et al. GH secretion in thalassemia patients with short stature. Hormone Res 1995; 44: 158-63.
38. Sklar CA, Lew LQ, Yoon DJ, David R. Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. JAMA SEA 1987; 3 (Suppl): 42-6.
39. Caruso NM, De Sanctis V, Capra M, et al. Short stature and body proportion in thalassaemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 11-6.
40. Garcia-Mayor RV, Andrade OA, Fernandez CP, Castro M, Rego IA, Reparaz A. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm Res 1993; 40: 189-93.
41. Kwan EY, Lee AC, Li AM, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassemia major in Hong Kong. J Pediatr Child Health 1995; 31: 83-7.
42. Saka N, Sukur M, Bundak R, et al. Growth and puberty in thalassemia major. J Pediatr Endocrin Metab 1995; 8: 181-6.
43. Vineenzo DS, Katz M, Vullo C, Bagni B, Ughi M, Wonke B. Effect of different treatment regimen on linear growth and final height in β-thalassemia major. Clin Endocrinol 1994; 41: 791-8.
44. Rodda CP, Reid ED, Johnson S et al. Short stature in homozygous β-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol 1995; 42: 587-92.
45. Fuchs GJ, Tienboon P, Khaled MA, et al. Nutritional support and growth in thalassemia major. Arch Dis Child 1997; 76: 509-12.
46. Tienboon P, Sanguansermsri T, Fuchs GJ. Malnutrition and growth abnormalities in children with Beta thalassemia major. Southeast Asian J Trop Med Public Health 1996; 27: 356-61.
47. Soliman AT, Elzalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusiondependent children and adolescents with thalassemia major and sickle cell diseases: a comparative study. J Trop Pediatr 1999; 45: 23-30.
48. Soliman AT, El Banna N, Abdel FM, et al. Bone mineral density in prepubertal children with betathalassemia: correlation with growth and hormonal data. Metabolism 1998; 47: 541-8.
49. Theodoridis C, Ladis V, Papatheodorou A, et al. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 835-44.
50. Cavallo L, Gurrado R, Zecchino C, et al. Shortterm therapy with recombinant growth hormone in polytransfused thalassemia major patients with growth deficiency. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 845-9.
51. Low LCK, Kwan EYW, Lim YJ, et al. Growth hormone treatment of short Chinese children with β-thalassemia major without growth hormone deficiency. Clin Endocrinol 1995; 42: 359-63.
52. Soliman AT, El Banna N, Ansari BM. GH response to provocation and circulation IGF-1 and IGF-binding protein-3 concentrations, the IGF-1 generation test and clinical response to GH therapy in children with beta-thalassemia. Eur J Endocrinol 1998; 138: 394-400.
53. De Sanctis V, Pinamnti A, Di Palma A, et al. Growth and development in thalassemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr 1996; 155: 368-72.
54. Weintrobe NB, Olivieri NF, Tyler B, et al. Effect of age at the start of iron chelation therapy on gonadal funtion in β-thalassemia major. New Engl J Med 1990; 323: 713-9.
55. Grundy RG, Woods KA, Savage MO, Evans JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child 1994; 71: 128-32.
56. Gabutti V, Piga AR. Results of long-term iron chelating therapy. Acta Haematol 1996; 95: 26-3.
57. Ponte G, Ferrara M, Esposito L. Growth in homozygous beta-thalassemia after bone marow transplantation. Bone Marrow Transplant 1991; 8 (Suppl 1); 68-9.
58. Simone MD, Olioso P, Bartolomeo PD, et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant 1995; 15: 227-33.
59. Cohen A, Van-Lint MT, Uderzo C, et al. Growth in patients after allogeneic bone marrow transplant for hematological disease in childhood. Bone Marrow Transplant 1995; 15: 343-8.